Company Announcements and Press Releases

Novo Nordisk country sites USA Argentina Australia Austria Belgium Brazil Bulgaria Canada Chile China Croatia Czech Republic Denmark Egypt Estonia Finland France Germany Greece Hungary India Iraq Ireland Israel Italy Japan Korea (Republic) Latvia Lebanon Lithuania Mexico Netherlands New Zealand Norway Pakistan Poland Portugal Romania Russian Federation Serbia Slovak Republic Slovenia South Africa Spain Sweden Switzerland Syria Taiwan Thailand Turkey Ukraine United Kingdom Other Novo Nordisk sites Changing diabetes NovoMedLink DAWN study Hagedorn Research Institute Diabetes4Patients Diabetes Barometer Changing diabetes bus Media prize World diabetes day School challenge Improve Control HRT for HCPs HRT for women HRT congresses & symposia

• News
• Facts about Novo Nordisk
• R&D pipeline
• Download centre
• Diabetes dictionary
• Broadcast room
• Photos
• Subscription
• Victoza® (liraglutide) press room
• Contact

• 
• Print

News

Novo Nordisk A/S - Share repurchase programme (8 March 2010)

Read the full announcement in PDF format

On 2 February 2010 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Further information:

Media:	Investors:
Elin K Hansen	Klaus Bülow Davidsen
Tel: (+45) 4442 3450	Tel: (+45) 4442 3176
ekh@novonordisk.com	klda@novonordisk.com
	Kasper Roseeuw Poulsen
	Tel: (+45) 4442 4471
	krop@novonordisk.com
In North America:	In North America:
Sean Clements	Hans Rommer
Tel: (+1) 609 514 8316	Tel: (+1) 609 919 7937
secl@novonordisk.com	hrmm@novonordisk.com

Company Announcement no 13 /2010